Hap Trading, LLC Intellia Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $609,296 - $810,210	11,300 New	11,300 $114,000
Q3 2021 Nov 10, 2021	SELL	$132.37 - $176.78 $1.71 Million - $2.28 Million	-12,900 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$60.88 - $161.91 $785,352 - $2.09 Million	12,900 New	12,900 $35,000
Q4 2020 Feb 16, 2021	SELL	$18.83 - $63.53 $199,597 - $673,418	-10,600 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$17.47 - $24.93 $185,182 - $264,258	10,600 New	10,600 $9,000
Q2 2020 Aug 10, 2020	SELL	$11.14 - $22.87 $268,474 - $551,167	-24,100 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$9.44 - $15.58 $8,496 - $14,022	900 Added 3.88%	24,100 $43,000
Q4 2019 Feb 11, 2020	BUY	$10.43 - $17.67 $241,976 - $409,944	23,200 New	23,200 $25,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.